The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.

Lubin, founder and CEO of a four-year-old online fashion marketplace and the Democratic challenger to U.S. Rep. Andrew ...

Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...

As more Big Pharma companies have launched direct-to-consumer telehealth platforms, lawmakers have raised concerns they might ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

It’s time to start thinking about seasonal vaccinations. Getting those annual jabs isn’t quite as simple as it was before the ...

These are four high-yield stocks that top-flight hedge fund managers have been buying as they wait for interest rates to drop ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

THE KICKOFF: Bruce Qi has dedicated his career to nurturing his passion for technology. He’s dabbled in entrepreneurship, ...

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months ...

The statement read: “NAFDAC enforcement officers, aided by intelligence from the Nigerian Army’s 15 Field Engineering ...

U.S. health officials are recommending that people 50 and older get a shot against bacteria that can cause pneumonia and ...